Skip to content

The research and application of an auxiliary diagnostic decision system for ovarian tumors based on a multimodal large model integrating ultrasound and clinical information

The research and application of an auxiliary diagnostic decision system for ovarian tumors based on a multimodal large model integrating ultrasound and clinical information

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129167
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian tumor

Interventions

Observation group:NA

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients in whom an ovarian tumor was detected by preoperative ultrasound (including lesions arising from the ovarian adnexa and fallopian tube) and who were ultimately confirmed by surgical pathology to have a non-physiological cyst; 2.Patients who underwent surgical treatment and had a pathological diagnosis; 3.The interval between ultrasound examination and surgery was no more than 30 days; 4.Patients with no prior history of ovarian cancer; 5.The interval between serum tumor marker CA125 testing and surgery was no more than 30 days. 6.The interval between exosomal OCS measurement and serum tumor marker CA125 testing and surgery must not exceed 30 days (prospective cohort only).

Exclusion criteria

Exclusion criteria: 1.Pregnant patients; 2.Patients who declined surgery after admission for personal reasons or underwent surgery at another hospital; 3.Cases in which surgical pathology confirmed broad ligament fibroids; 4.Cases in which surgical pathology showed only a physiological cyst; 5.Cases with indeterminate histopathological results; 6.Any congenital conditions involving abnormal ovarian development or gonadal dysgenesis (including but not limited to intersex disorders); 7.Patients diagnosed with a malignant tumor who had not achieved complete remission (CR), or who had achieved CR but had an interval of less than 1 year since the last chemotherapy; 8.Patients who participated in an interventional clinical trial before enrollment that could affect the determination of the primary outcome; 9.Preoperative ultrasound images of inadequate quality (images not retained or image quality too poor);

Design outcomes

Primary

MeasureTime frame
Multi-Class Area Under the (ROC) Curve;

Countries

China

Contacts

Public ContactWeiwei Feng

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

fww12066@rjh.com.cn+86 21 64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026